Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V R McCready

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
The British Journal of Radiology|December 1, 1984
A clinical evaluation of a prototype positron camera for longitudinal emission tomographyM A Flower, R J Ott, S Webb, et al.
The British Journal of Radiology|March 1, 1987
Measurement of radiation dose to the thyroid using positron emission tomographyR J Ott, V Batty, B S Webb, et al.
British Journal of Cancer|December 18, 2001
Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastasesD Burke, M M Davies, J Zweit, et al.
Nuclear Medicine Communications|September 1, 1993
Cellular versus vascular rejection in transplant kidneys. Correlation of radionuclide and Doppler studies with histologyA M al-Nahhas, R Kedar, S H Morgan, et al.
NMR in Biomedicine|December 22, 1998
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatmentM O Leach, M Verrill, J Glaholm, et al.
The British Journal of Radiology|February 1, 1983
The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodiesR J Ott, L J Grey, M A Zivanovic, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2006
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to boneJ M O'Sullivan, A R Norman, V R McCready, et al.
European Journal of Nuclear Medicine|February 24, 2001
62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastasesM A Flower, J Zweit, A D Hall, et al.
British Journal of Cancer|June 28, 2002
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to boneJ M O'Sullivan, V R McCready, G Flux, et al.
World Journal of Nuclear Medicine|May 2, 2019
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinomaS Dizdarevic, M Tulchinsky, V R McCready, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
The British Journal of Radiology|December 1, 1984
A clinical evaluation of a prototype positron camera for longitudinal emission tomographyM A Flower, R J Ott, S Webb, et al.
The British Journal of Radiology|March 1, 1987
Measurement of radiation dose to the thyroid using positron emission tomographyR J Ott, V Batty, B S Webb, et al.
British Journal of Cancer|December 18, 2001
Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastasesD Burke, M M Davies, J Zweit, et al.
Nuclear Medicine Communications|September 1, 1993
Cellular versus vascular rejection in transplant kidneys. Correlation of radionuclide and Doppler studies with histologyA M al-Nahhas, R Kedar, S H Morgan, et al.
NMR in Biomedicine|December 22, 1998
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatmentM O Leach, M Verrill, J Glaholm, et al.
The British Journal of Radiology|February 1, 1983
The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodiesR J Ott, L J Grey, M A Zivanovic, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2006
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to boneJ M O'Sullivan, A R Norman, V R McCready, et al.
European Journal of Nuclear Medicine|February 24, 2001
62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastasesM A Flower, J Zweit, A D Hall, et al.
British Journal of Cancer|June 28, 2002
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to boneJ M O'Sullivan, V R McCready, G Flux, et al.
World Journal of Nuclear Medicine|May 2, 2019
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinomaS Dizdarevic, M Tulchinsky, V R McCready, et al.
Pageof 15